Affinity DataIC50: 11nMT: 2°CAssay Description:The composition of the binding assay buffer is determined in a course of detailed optimization procedure. This resulted in a binding assay buffer con...More data for this Ligand-Target Pair
Affinity DataIC50: 11nMAssay Description:Displacement of [125I]-CXCL10 from human recombinant CXCR3 transfected in Flp-In-CHO cell membranes after 60 mins by gamma counting methodMore data for this Ligand-Target Pair
Affinity DataIC50: 12nMT: 2°CAssay Description:The composition of the binding assay buffer is determined in a course of detailed optimization procedure. This resulted in a binding assay buffer con...More data for this Ligand-Target Pair
Affinity DataIC50: 13nMAssay Description:Competition radioligand binding assays were performed to determine the in vitro potency of the newly synthesized, unlabeled test compounds to displac...More data for this Ligand-Target Pair
Affinity DataIC50: 13nMAssay Description:Displacement of [125I]-CXCL10 from human recombinant CXCR3 transfected in Flp-In-CHO cell membranes after 60 mins by gamma counting methodMore data for this Ligand-Target Pair
Affinity DataIC50: 15nMAssay Description:Competition radioligand binding assays were performed to determine the in vitro potency of the newly synthesized, unlabeled test compounds to displac...More data for this Ligand-Target Pair
Affinity DataIC50: 19nMAssay Description:Displacement of [125I]-CXCL10 from human recombinant CXCR3 transfected in Flp-In-CHO cell membranes after 60 mins by gamma counting methodMore data for this Ligand-Target Pair
Affinity DataIC50: 19nMAssay Description:Displacement of [125I]-CXCL10 from human recombinant CXCR3 transfected in Flp-In-CHO cell membranes after 60 mins by gamma counting methodMore data for this Ligand-Target Pair
Affinity DataIC50: 19nMT: 2°CAssay Description:The composition of the binding assay buffer is determined in a course of detailed optimization procedure. This resulted in a binding assay buffer con...More data for this Ligand-Target Pair
Affinity DataIC50: 19nMAssay Description:Competition radioligand binding assays were performed to determine the in vitro potency of the newly synthesized, unlabeled test compounds to displac...More data for this Ligand-Target Pair
Affinity DataIC50: 19nMAssay Description:Competition radioligand binding assays were performed to determine the in vitro potency of the newly synthesized, unlabeled test compounds to displac...More data for this Ligand-Target Pair
TargetUbiquitin carboxyl-terminal hydrolase 7(Homo sapiens (Human))
Les Laboratoires Servier
US Patent
Les Laboratoires Servier
US Patent
Affinity DataIC50: 19.6nMAssay Description:USP7 activity was measured using Rhodamine-110 c-terminal labelled Ubiquitin as a substrate (Viva Biosciences). Incubation with USP7 results in the r...More data for this Ligand-Target Pair
Affinity DataIC50: 20nMT: 2°CAssay Description:The composition of the binding assay buffer is determined in a course of detailed optimization procedure. This resulted in a binding assay buffer con...More data for this Ligand-Target Pair
Affinity DataIC50: 20nMAssay Description:Competition radioligand binding assays were performed to determine the in vitro potency of the newly synthesized, unlabeled test compounds to displac...More data for this Ligand-Target Pair
Affinity DataIC50: 20nMT: 2°CAssay Description:The composition of the binding assay buffer is determined in a course of detailed optimization procedure. This resulted in a binding assay buffer con...More data for this Ligand-Target Pair
Affinity DataIC50: 20nMT: 2°CAssay Description:The composition of the binding assay buffer is determined in a course of detailed optimization procedure. This resulted in a binding assay buffer con...More data for this Ligand-Target Pair
Affinity DataIC50: 21nMAssay Description:Displacement of [125I]-CXCL10 from human recombinant CXCR3 transfected in Flp-In-CHO cell membranes after 60 mins by gamma counting methodMore data for this Ligand-Target Pair
Affinity DataIC50: 22nMAssay Description:Competition radioligand binding assays were performed to determine the in vitro potency of the newly synthesized, unlabeled test compounds to displac...More data for this Ligand-Target Pair
Affinity DataIC50: 23nMAssay Description:Displacement of [125I]-CXCL10 from human recombinant CXCR3 transfected in Flp-In-CHO cell membranes after 60 mins by gamma counting methodMore data for this Ligand-Target Pair
Affinity DataIC50: 23nMAssay Description:Displacement of [125I]-CXCL10 from human recombinant CXCR3 transfected in Flp-In-CHO cell membranes after 60 mins by gamma counting methodMore data for this Ligand-Target Pair
Affinity DataIC50: 23nMT: 2°CAssay Description:The composition of the binding assay buffer is determined in a course of detailed optimization procedure. This resulted in a binding assay buffer con...More data for this Ligand-Target Pair
Affinity DataIC50: 23nMAssay Description:Competition radioligand binding assays were performed to determine the in vitro potency of the newly synthesized, unlabeled test compounds to displac...More data for this Ligand-Target Pair
Affinity DataIC50: 23nMT: 2°CAssay Description:The composition of the binding assay buffer is determined in a course of detailed optimization procedure. This resulted in a binding assay buffer con...More data for this Ligand-Target Pair
Affinity DataIC50: 24nMAssay Description:Displacement of [125I]-CXCL10 from human recombinant CXCR3 transfected in Flp-In-CHO cell membranes after 60 mins by gamma counting methodMore data for this Ligand-Target Pair
Affinity DataIC50: 25nMAssay Description:Displacement of [125I]-CXCL10 from human recombinant CXCR3 transfected in Flp-In-CHO cell membranes after 60 mins by gamma counting methodMore data for this Ligand-Target Pair
Affinity DataIC50: 25nMAssay Description:Competition radioligand binding assays were performed to determine the in vitro potency of the newly synthesized, unlabeled test compounds to displac...More data for this Ligand-Target Pair
Affinity DataIC50: 25nMAssay Description:Competition radioligand binding assays were performed to determine the in vitro potency of the newly synthesized, unlabeled test compounds to displac...More data for this Ligand-Target Pair
Affinity DataIC50: 25nMT: 2°CAssay Description:The composition of the binding assay buffer is determined in a course of detailed optimization procedure. This resulted in a binding assay buffer con...More data for this Ligand-Target Pair
Affinity DataIC50: 26nMAssay Description:Competition radioligand binding assays were performed to determine the in vitro potency of the newly synthesized, unlabeled test compounds to displac...More data for this Ligand-Target Pair
Affinity DataIC50: 26nMAssay Description:Displacement of [125I]-CXCL10 from human recombinant CXCR3 transfected in Flp-In-CHO cell membranes after 60 mins by gamma counting methodMore data for this Ligand-Target Pair
Affinity DataIC50: 28nMT: 2°CAssay Description:The composition of the binding assay buffer is determined in a course of detailed optimization procedure. This resulted in a binding assay buffer con...More data for this Ligand-Target Pair
Affinity DataIC50: 28nMAssay Description:Competition radioligand binding assays were performed to determine the in vitro potency of the newly synthesized, unlabeled test compounds to displac...More data for this Ligand-Target Pair
TargetUbiquitin carboxyl-terminal hydrolase 7(Homo sapiens (Human))
Les Laboratoires Servier
US Patent
Les Laboratoires Servier
US Patent
Affinity DataIC50: 28.7nMAssay Description:USP7 activity was measured using Rhodamine-110 c-terminal labelled Ubiquitin as a substrate (Viva Biosciences). Incubation with USP7 results in the r...More data for this Ligand-Target Pair
Affinity DataIC50: 30nMT: 2°CAssay Description:The composition of the binding assay buffer is determined in a course of detailed optimization procedure. This resulted in a binding assay buffer con...More data for this Ligand-Target Pair
Affinity DataIC50: 31nMAssay Description:Displacement of [125I]-CXCL10 from human recombinant CXCR3 transfected in Flp-In-CHO cell membranes after 60 mins by gamma counting methodMore data for this Ligand-Target Pair
Affinity DataIC50: 31nMT: 2°CAssay Description:The composition of the binding assay buffer is determined in a course of detailed optimization procedure. This resulted in a binding assay buffer con...More data for this Ligand-Target Pair
Affinity DataIC50: 31nMT: 2°CAssay Description:The composition of the binding assay buffer is determined in a course of detailed optimization procedure. This resulted in a binding assay buffer con...More data for this Ligand-Target Pair
Affinity DataIC50: 31nMT: 2°CAssay Description:The composition of the binding assay buffer is determined in a course of detailed optimization procedure. This resulted in a binding assay buffer con...More data for this Ligand-Target Pair
TargetUbiquitin carboxyl-terminal hydrolase 7(Homo sapiens (Human))
Les Laboratoires Servier
US Patent
Les Laboratoires Servier
US Patent
Affinity DataIC50: 31.6nMAssay Description:USP7 activity was measured using Rhodamine-110 c-terminal labelled Ubiquitin as a substrate (Viva Biosciences). Incubation with USP7 results in the r...More data for this Ligand-Target Pair
Affinity DataIC50: 32nMAssay Description:Displacement of [125I]-CXCL10 from human recombinant CXCR3 transfected in Flp-In-CHO cell membranes after 60 mins by gamma counting methodMore data for this Ligand-Target Pair
Affinity DataIC50: 32nMAssay Description:Competition radioligand binding assays were performed to determine the in vitro potency of the newly synthesized, unlabeled test compounds to displac...More data for this Ligand-Target Pair
Affinity DataIC50: 32nMT: 2°CAssay Description:The composition of the binding assay buffer is determined in a course of detailed optimization procedure. This resulted in a binding assay buffer con...More data for this Ligand-Target Pair
Affinity DataIC50: 34nMAssay Description:Displacement of [125I]-CXCL10 from human recombinant CXCR3 transfected in Flp-In-CHO cell membranes after 60 mins by gamma counting methodMore data for this Ligand-Target Pair
Affinity DataIC50: 34nMT: 2°CAssay Description:The composition of the binding assay buffer is determined in a course of detailed optimization procedure. This resulted in a binding assay buffer con...More data for this Ligand-Target Pair
Affinity DataIC50: 34nMT: 2°CAssay Description:The composition of the binding assay buffer is determined in a course of detailed optimization procedure. This resulted in a binding assay buffer con...More data for this Ligand-Target Pair
Affinity DataIC50: 35nMAssay Description:Competition radioligand binding assays were performed to determine the in vitro potency of the newly synthesized, unlabeled test compounds to displac...More data for this Ligand-Target Pair
Affinity DataIC50: 35nMAssay Description:Displacement of [125I]-CXCL10 from human recombinant CXCR3 transfected in Flp-In-CHO cell membranes after 60 mins by gamma counting methodMore data for this Ligand-Target Pair
Affinity DataIC50: 36nMAssay Description:Displacement of [125I]-CXCL10 from human recombinant CXCR3 transfected in Flp-In-CHO cell membranes after 60 mins by gamma counting methodMore data for this Ligand-Target Pair
Affinity DataIC50: 37nMAssay Description:Displacement of [125I]-CXCL10 from human recombinant CXCR3 transfected in Flp-In-CHO cell membranes after 60 mins by gamma counting methodMore data for this Ligand-Target Pair
Affinity DataIC50: 37nMAssay Description:Competition radioligand binding assays were performed to determine the in vitro potency of the newly synthesized, unlabeled test compounds to displac...More data for this Ligand-Target Pair